Opioid receptor modulation of norepinephrine secretion in the caudal dorsomedial medulla of rats: in vivo studies

dc.creatorRussell, Amy Lynn
dc.date.accessioned2016-11-14T23:15:03Z
dc.date.available2011-02-18T20:06:17Z
dc.date.available2016-11-14T23:15:03Z
dc.date.issued2001-05
dc.degree.departmentZoologyen_US
dc.description.abstractOur knowledge of how opioids mfluence brainstem neurochemistry is derived principally from in vitro studies. Before we can fiiUy understand how opioids impact cardiovascular function, it is necessary to learn more about their role in vivo. Using microdialysis, male Sprague-Dawley rats were perfused with a microdialysis probe located adjacent to the nucleus of the solitary tract (nTS), with Ringer's, or Ringer's containing beta-endorphin or the selective opioid receptor agonists, [D-Ala^ N-Me-Phe^ Gly-ol]-Enkephalm(DAMGO), U-50488H. or [DPen23]-Enkephalin (non-pCL DPDPE). Microdialysate samples were collected and analyzed for norepinephrine (NE) by high performance liquid chromatography electrochemical (HPLC-EC) detection. DAMGO, a selective muopioid agonist, inhibited potassium (K^)-induced NE release in the nTS. DPDPE, a selective deltaopioid agonist and U-50488H, a kappa-agonist, did not have any affects on K^-induced NE release in the nTS. DAMGO effects on NE secretion were not observed in the presence of the mu/delta selective-opioid receptor antagonist, naloxone. These studies illustrate the ability of selective opioid receptor agonists to influence K"^ -evoked NE release and that the inhibitory effects are mediated through mu-opioid receptors in vivo.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttp://hdl.handle.net/2346/12913en_US
dc.language.isoeng
dc.publisherTexas Tech Universityen_US
dc.rights.availabilityUnrestricted.
dc.subjectRatsen_US
dc.subjectNoradrenalineen_US
dc.subjectOpioidsen_US
dc.titleOpioid receptor modulation of norepinephrine secretion in the caudal dorsomedial medulla of rats: in vivo studies
dc.typeThesis

Files